Sepsis in ICU:Causes and Outcomes in Diabetics and Non Diabetics

Sepsis Clinical Trial

Official title:

Sepsis in ICU: Causes and Outcomes in Diabetics and Non Diabetics in Assiut University Hospital

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05914480
• Other study ID #: Sepsis pts investigate causes
• Status: Not yet recruiting
• Start date: July 2023
• Est. completion date: August 2024

Study information

• Verified date: June 2023
• Source: Assiut University
• Contact: Mai Ahmed fathi, Specialist
• Phone: 01009490399
• Email: doc.maiahmad89[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Identify prevalence of sepsis in ICU of Assiut university hospital 2.Clarify different causes of sepsis in patients admitted to ICU . 3.Compare causes and outcomes of sepsis between diabetics versus non diabetics .

4.Screening for the co1.mmonest organism causing sepsis in critically ill patients .

Description:

Sepsis, is defined as an infection with organ dysfunction, There is wide variation in sepsis rates, causative microorganisms, and outcome in ICU patients around the world.

Many conservative estimates considered sepsis as a leading cause of mortality and critical illness worldwide .

sepsis epidemiology studies worldwide revealed a highly variable incidence of 13-300 per 100,000 inhabitants per year for severe sepsis and 11 per 100,000 inhabitants per year for septic shock .

Factors such as advancing age, immunosuppression and multidrug-resistant infection play a role in increasing incidence of sepsis during recent decades .

Patients who survive sepsis often have long-term physical, psychological, and cognitive disabilities with significant health and social implications.

Patients with diabetes mellitus have an increased risk of developing infections and sepsis and they constitute 20.1-22.7% of all sepsis patients.

The prevalence of diabetes mellitus in ICU patients is as high as 30%, And such patients are at increased risk of experiencing in-hospital Complications, compared to patients without diabetes.

Infective complications may be reduced with lower blood glucose concentrations Moreover, in critically ill patients without diabetes, Hyperglycemia is associated with increased mortality, risk of infection, Kidney injury and cardiovascular complications.

Moreover, diabetes is a major risk factor for both Acute Kidney Injury and sepsis.

Sepsis also is a major cause of Acute Kidney Injury, which develops in one-fourth of all patients with sepsis and half of patients with bacteraemia or shock .

Sepsis-related AKI is associated with high mortality rates of up to 70%.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 85
• Est. completion date: August 2024
• Est. primary completion date: July 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• according to sofa criteria Suspected /documented infection+sofa score >_2 or +ve Q sofa defined as 2or more 1_ hypotesion SBP<90.2_altered mental status GCS<13 3_ Exclusion Criteria:tachypnea>22 or septic shock criteria

• previous history of pulmonary problem Previous history of cardiac disease Previous history of autoimmune disease

Related Conditions & MeSH terms

• Sepsis
• Toxemia

Intervention

Other:
• PCR for legionella ,blood ,urine cultures and from catheters or source of infection
Investigations to detect cause of sepsis as blood cultures ,urine cultures and from catheters .also PCR for legionella will be done

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Detect the most common organism causing sepsis in ICU	Applying culture and sensitivity test for patients developed sepsis on admission and follow up will direct us for appropriate treatment for all patients	20 days
Secondary	Incidence of sepsis in diabetics versus non diabetics in ICU.	Assess the effect of hyperglycemia on spsis outcomes.	15 days